购物车
- 全部删除
- 您的购物车当前为空
Hydroxyzine dihydrochloride (Hydroxyzine 2HCl) 是一种苯二氮卓抗组胺剂,是可口服的组胺 H1 受体和血清素拮抗剂,可有效治疗慢性荨麻疹、皮炎和组胺介导的瘙痒。它还可以作为止吐剂和镇静剂,有缓解焦虑和紧张的作用。
Hydroxyzine dihydrochloride (Hydroxyzine 2HCl) 是一种苯二氮卓抗组胺剂,是可口服的组胺 H1 受体和血清素拮抗剂,可有效治疗慢性荨麻疹、皮炎和组胺介导的瘙痒。它还可以作为止吐剂和镇静剂,有缓解焦虑和紧张的作用。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
50 mg | ¥ 112 | 现货 | |
100 mg | ¥ 195 | 现货 | |
200 mg | ¥ 262 | 现货 | |
500 mg | ¥ 427 | 现货 | |
1 g | ¥ 625 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 99 | 现货 |
产品描述 | Hydroxyzine dihydrochloride (Hydroxyzine 2HCl) is a histamine H1 receptor antagonist that is effective in the treatment of chronic urticaria, dermatitis, and histamine-mediated pruritus. Unlike its major metabolite CETIRIZINE, it does cause drowsiness. It is also effective as an antiemetic, for relief of anxiety and tension, and as a sedative. |
靶点活性 | H1 receptor:10 nM-19 nM |
体外活性 | 在甩尾试验中,腹腔注射12.5 mg/kg Hydroxyzine降低吗啡在大鼠体内的镇痛作用而腹腔注射50 mg/kg Hydroxyzine加强吗啡的作用.500 μM Hydroxyzine使稳态的依托泊苷浓度明显降低2倍,在Sprague-Dawley大鼠体内的稳态浓度达到0.055 μM/mL. |
体内活性 | 0.1 mM Hydroxyzine抑制实验性变应性脑脊髓炎Lewis大鼠体内50%的EAE恶化,且抑制70%肥大细胞脱颗粒作用。10 μM Hydroxyzine在预处理的膀胱切片中经过60分钟,抑制34%的10 μM的卡巴胆碱诱导的5-羟色胺释放,1 μM抑制25%,0.1 μM抑制17%。500 μM Hydroxyzine明显增加空肠外翻囊中依托泊苷到浆膜部位的运输。Hydroxyzine明显降低空肠和回肠中大约2.4 μg/mL的依托泊苷流出。 |
别名 | 盐酸羟嗪, Hydroxyzine 2HCl |
分子量 | 447.83 |
分子式 | C21H27ClN2O2·2HCl |
CAS No. | 2192-20-3 |
Smiles | C1CN(CCN1CCOCCO)C(c1ccccc1)c1ccc(cc1)Cl.Cl.Cl |
密度 | 1.182 g/cm3 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
溶解度信息 | H2O: 201 mM DMSO: 55 mg/mL (122.81 mM) | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容